Medicare Enrolled
Dr. Mansoor Shah, MD
Internal Medicine · Lakewood, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Mansoor Shah is an internal medicine specialist in Lakewood, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 924 Medicare services across 410 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $12,793 from 65 pharmaceutical and/or device companies across 697 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 34% volume in CA
$12,793 industry payments
Medicare Practice Summary
Medicare Utilization ↗924
Medicare services
Top 34% in CA for internal medicine
410
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~49 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
215 | $66 | $150 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
172 | $43 | $80 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
121 | $34 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
118 | $90 | $215 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
113 | $47 | $90 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
49 | $143 | $350 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
33 | $34 | $40 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
32 | $72 | $120 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
25 | $18 | $35 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
21 | $23 | $60 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $144 | $300 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
11 | $11 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,793
Total received (2018-2024)
Avg $1,828/year across 7 years
Top 8% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
697
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,793 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,242
2023
$2,409
2022
$1,930
2021
$2,266
2020
$1,204
2019
$1,268
2018
$1,475
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$289
PFIZER INC.
$246
Lilly USA, LLC
$187
GENZYME CORPORATION
$175
Bayer Healthcare Pharmaceuticals Inc.
$149
Boehringer Ingelheim Pharmaceuticals, Inc.
$115
Novo Nordisk Inc
$107
Astellas Pharma US Inc
$100
Regeneron Healthcare Solutions, Inc.
$94
AstraZeneca Pharmaceuticals LP
$91
Fresenius Kabi USA, LLC
$86
Sumitomo Pharma America, Inc.
$82
Phathom Pharmaceuticals, Inc.
$69
Amgen Inc.
$69
Merck Sharp & Dohme LLC
$56
Otsuka America Pharmaceutical, Inc.
$45
Dexcom, Inc.
$36
Averitas Pharma Inc.
$31
Boston Scientific Corporation
$30
UCB, Inc.
$29
Neuronetics, Inc.
$27
Gilead Sciences, Inc.
$27
Abbott Laboratories
$23
IBSA Pharma Inc.
$22
Exact Sciences Corporation
$21
Paratek Pharmaceuticals, Inc.
$19
SANOFI-AVENTIS U.S. LLC
$17
Top 3 companies account for 32.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,574
Lilly USA, LLC
$1,065
Astellas Pharma US Inc
$900
PFIZER INC.
$846
AstraZeneca Pharmaceuticals LP
$746
Novartis Pharmaceuticals Corporation
$637
Novo Nordisk Inc
$562
Amgen Inc.
$558
GENZYME CORPORATION
$501
Janssen Pharmaceuticals, Inc
$496
Merck Sharp & Dohme Corporation
$456
Boehringer Ingelheim Pharmaceuticals, Inc.
$309
Bayer Healthcare Pharmaceuticals Inc.
$260
Bayer HealthCare Pharmaceuticals Inc.
$232
AbbVie Inc.
$207
Fresenius Kabi USA, LLC
$205
Regeneron Healthcare Solutions, Inc.
$203
Merck Sharp & Dohme LLC
$184
E.R. Squibb & Sons, L.L.C.
$183
SANOFI-AVENTIS U.S. LLC
$182
Abbott Laboratories
$174
Otsuka America Pharmaceutical, Inc.
$130
Esperion Therapeutics, Inc.
$129
Indivior Inc.
$125
Biohaven Pharmaceuticals, Inc.
$109
Eisai Inc.
$107
Radius Health, Inc.
$102
Dexcom, Inc.
$95
Biohaven Pharmaceutical Holding Company Ltd.
$85
Sumitomo Pharma America, Inc.
$82
Gilead Sciences, Inc.
$80
Mallinckrodt Hospital Products Inc.
$80
SANOFI PASTEUR INC.
$79
Ultragenyx Pharmaceutical Inc.
$78
Allergan, Inc.
$76
Takeda Pharmaceuticals U.S.A., Inc.
$69
Phathom Pharmaceuticals, Inc.
$69
Intercept Pharmaceuticals, Inc.
$67
Amarin Pharma Inc.
$64
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$59
UCB, Inc.
$55
Teva Pharmaceuticals USA, Inc.
$42
Allergan Inc.
$42
AbbVie, Inc.
$40
Mallinckrodt Enterprises LLC
$33
Averitas Pharma Inc.
$31
Boston Scientific Corporation
$30
ABBVIE INC.
$28
Bardy Diagnostics, Inc.
$28
Neuronetics, Inc.
$27
Hologic, LLC
$25
Nevro Corp.
$23
IBSA Pharma Inc.
$22
Exact Sciences Corporation
$21
Shield Therapeutics Inc
$20
Paratek Pharmaceuticals, Inc.
$19
Lucid Diagnostics Inc.
$19
Linus Health, Inc.
$18
Pharming Healthcare, Inc.
$17
IDORSIA PHARMACEUTICALS US INC
$16
Sun Pharmaceutical Industries Inc.
$16
Medtronic Vascular, Inc.
$15
Cumberland Pharmaceuticals, Inc.
$14
Janssen Biotech, Inc.
$13
Medtronic MiniMed, Inc.
$11
Top 3 companies account for 27.7% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · ADACEL · AIRSUPRA · ANORO · ANORO ELLIPTA · APTIMA · AUSTEDO · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BENLYSTA · BREZTRI · Bimzelx · CORE COGNITIVE EVALUATION · COSENTYX · CREON · CRYSVITA · Carnation Ambulatory Monitor · Cimzia · Cologuard Collection Kit · Cryvista · DUPIXENT · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · GARDASIL 9 · GEMTESA · INVOKANA · JANUVIA · JARDIANCE · JYNARQUE · KAPSPARGO · KEVZARA · Kerendia · LEQVIO · MOUNJARO · MYRBETRIQ · Myrbetriq · NEUROSTAR TMS THERAPY SYSTEM · NEXLETOL · NEXLIZET · NURTEC ODT · NUZYRA · OCALIVA · OFEV · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · QULIPTA · QUTENZA · QUVIVIQ · REDITREX · REXULTI · RINVOQ · RUCONEST · Repatha · Reveal LINQ · Rinvoq · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SUBLOCADE · SYMBICORT · Senza · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TREMFYA · TRULICITY · TZIELD · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · VESICARE · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · WATCHMAN FLX · XARELTO · XELJANZ · XIFAXAN · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
5,346
Per 100K population
54.3
County median income
$87,760
Nearest hospital
UCI HEALTH-LAKEWOOD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 8% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Shah performed 215 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $12,793 from 65 companies across 697 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other internal medicine physicians in Lakewood?
Dr. Shah's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Lakewood
Browse internal medicine physicians in Lakewood ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology